Riley Catenacci, PhD
Breaking the barriers to remyelination in multiple sclerosis. (2022) Current Opinions in Pharmacology.
Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis drugs in vitro. (2024) Neurotherapeutics.
MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis.(2023) eLife.
How do immune oligodendroglia contribute to failed remyelination in multiple sclerosis?
MHC Class II induction in oligodendroglia varies with age. (2023) Society for Neuroscience.
What is Social Rhythm Therapy That Could Reduce Suicide Risk in Bipolar Disorder? (2023) Sparrow Science.
Fidgeting into Focus. (2021) Johns Hopkins Biomedical Odyssey.
Alexandra Feodorovna and Somatic Symptom Disorder: Unraveling the Health Struggles of Russia's Last Empress. (2024). Uneasy Lies the Crown.